XML 62 R46.htm IDEA: XBRL DOCUMENT v3.26.1
BUSINESS COMBINATIONS (Details Narrative) - USD ($)
12 Months Ended
Oct. 25, 2024
Dec. 31, 2025
Dec. 31, 2024
Oct. 05, 2017
Business Combination [Line Items]        
Common stock, shares authorized 3,389,169 400,000,000 400,000,000  
Common stock, par value $ 0.092 $ 0.001 $ 0.001  
Preferred stock, shares authorized 28,467,564 50,000,000 50,000,000  
Preferred stock, par value $ 0.428 $ 0.001 $ 0.001  
Common stock, shares outstanding   108,147,731 86,782,908  
Fair value patent amount   $ 24,570,000    
License and patent carrying value   0    
Subsidiary integration   $ 12,469,940    
NDPD Pharma Inc [Member]        
Business Combination [Line Items]        
Business Combination, Voting Equity Interest Acquired, Percentage 100.00%      
Acquisition of shares 14,085,410      
Common stock, shares authorized       95,000,000
Common stock, par value $ 0.091     $ 0.0001
Preferred stock, shares authorized       5,000,000
Preferred stock, par value $ 0.427     $ 0.0001
Common stock, shares outstanding   15,000,000    
Fair market value $ 7,660,000      
Book value 4,007,572      
License Agreement $ 8,190,000      
NDPD Pharma Inc [Member] | Stock Purchase Agreement [Member]        
Business Combination [Line Items]        
Business Combination, Voting Equity Interest Acquired, Percentage 100.00%      
NDPD Pharma Inc [Member] | Stock Purchase Agreement [Member] | Non Affiliates [Member]        
Business Combination [Line Items]        
Acquisition of shares 3,389,169      
NDPD Pharma Inc [Member] | Stock Purchase Agreement [Member] | Affiliates [Member]        
Business Combination [Line Items]        
Acquisition of shares 28,467,564